Moderna has requested permission to use booster doses that contain 50 micrograms of the vaccine – half the usual dose.

The Advisory Board of the Food and Drug Administration (FDA) under the U.S. Department of Health and Human Services spoke in favor of approving the use of booster doses of the coronavirus vaccine from Moderna for residents of the country aged 65 and over, as well as people who, due to their health condition, are at significant risk of severe disease or are at high risk of infection due to their professional activities. American news TV channels broadcasted the council meeting.

The FDA experts unanimously supported the relevant recommendation. Moderna has requested permission to use booster doses that contain 50 micrograms of the vaccine – half the usual dose of 100 micrograms.

As The Washington Post explains, the experts’ recommendation will be reviewed by FDA officials, who will make a final decision on the Moderna application in the coming days. After that, the Federal Centers for Disease Control and Prevention will give recommendations on using booster doses of the Moderna vaccine.

Only additional doses of the coronavirus vaccine from the American company Pfizer and the German BioNTech are allowed in the United States. As in the situation with the Moderna drug, we are talking only about people over 65 years of age and people at significant risk of severe disease or high risk of infection.